History of Juvent

Juvent didn’t start as a company trying to enter the wellness market.

It started as a scientific effort to address a serious human problem: bone loss in extreme conditions where the body begins to break down.

Long before it became something you could use at home, this technology was being studied for use in one of the most demanding environments imaginable—space.

In the 1990s, researchers such as innovator and pioneer Jack Ryaby began investigating a major challenge faced by astronauts. In zero gravity, the body rapidly loses bone density. Without the constant, mechanical micro-impacts created by walking and movement on Earth, the skeletal system weakens… fast.

To address this, scientific teams explored whether precise, low-level mechanical stimulation could replicate the natural, micro-impact signals the body depends on to stay strong.

This research, supported in part by NASA-funded studies, led to a major breakthrough.

The body doesn’t need more force.

It needs the right kind of micro-impact pulses.

This discovery became the foundation of what was first called Mechanical Stress Technology (MST).

At the time, most solutions focused on intensity. More impact, more strain, more effort, but MST challenged that thinking. Instead of overwhelming the body, it worked with it, using gentle, calibrated stimulation to support natural biological processes like:

• Bone formation
• Circulation
• Cellular communication

It was a fundamentally different approach, supporting the body, not forcing it.

The story of Micro-Impact begins with the vision of Jack Ryaby, a true pioneer whose 40-year career in orthopedics places him among the great inventors of our time. Ryaby dedicated his career to the mechanical frequencies the human skeleton responds to. Widely recognized as the "father" of bone growth stimulation, he was instrumental in developing the first cleared devices that used targeted energy to influence bone biology.

That insight — that precise, low-magnitude energy could communicate directly with living bone — found its clinical home in 1993, when Ryaby founded EBI. His mission was to bridge the gap between laboratory discovery and life-changing medical application. A holder of numerous patents, his work was defined by an uncompromising commitment to professional integrity and clinical evidence. This evolution from theory to a revered medical standard for Micro-Impact Technology was solidified through years of rigorous validation:

• Pioneering Breakthroughs: Ryaby led extensive animal studies that proved the mechanical stimulation of bone growth was not just possible, but repeatable.
• The Space Frontier: His technology was chosen for a NASA-supported study to explore the prevention of bone loss in the extreme environment of space.
• Clinical Validation: A landmark clinical trial found significantly less bone loss among post-menopausal women using the technology.

Jack Ryaby didn't just build a device; he unlocked a biological language. This was measurable, repeatable science that ultimately led to a public offering and acquisition by Smith & Nephew, cementing his invention as a cornerstone of modern medical technology. Today, we treat this technology with the reverence it deserves—as the crowning achievement of a man who changed the trajectory of skeletal health forever.

Despite strong validation, the technology was sidelined during corporate restructuring, but for those who understood its potential, this wasn’t the end. In 2003, Jack Ryaby reacquired the rights and founded Juvent Medical Corporation with a clear purpose:

To take this breakthrough technology out of the lab and make it available to people who needed it. Over the next several years, the company invested heavily in:

• Randomized, controlled clinical trials
• Patent protection and engineering refinement
• Development of the first Juvent platform
• International regulatory approvals

This was about delivering something meaningful.

Setbacks, Not Failure.

After the unexpected passing of its founder, Juvent faced leadership challenges during the global financial crisis. In 2009, operations ceased, but the story didn’t end there.

Because the technology worked, and the research supported it.

In 2011, a new team of medical device innovators recognized what had been left behind. They saw one of the most underutilized breakthroughs in regenerative health.

This led to the formation of Regenerative Technologies Corporation (RTC), which acquired the Juvent technology and began rebuilding it with a long-term purpose.

By 2012, Juvent returned as a daily tool designed to support how the body actually works.

The science behind Micro-Impact has been studied for 60 years. The Juvent Micro-Impact Platform® itself has been in continuous development since 2011.

That distinction matters. Newer wellness devices rely on aggressive force. Juvent's Dynamic Motion Therapy® was engineered to do the opposite — deliver the smallest effective mechanical signal, calibrated to each body, rather than the largest.

• Decades of Validation: Supported by 60+ peer-reviewed papers, clinical trials, and clinical studies — a research library more extensive than newer entrants to the category.
• Unmatched Investment: Backed by $45 million in Research & Development.
• Proprietary Innovation: Protected by 20+ patents that safeguard our unique low-impact frequency.
• Engineered for Safety: Specifically designed for safe, daily use without the strain or physical extremes associated with high-impact alternatives.

Clinical research, including a landmark published study in JAMA Oncology, has demonstrated measurable improvements in bone density using this precise, low-impact approach. Because the technology is rooted in 60 years of research rather than recent trends, users report improvements in:

• Mobility and Balance
• Circulation and Swelling
• Recovery and Daily Energy
• Chronic Discomfort and Stiffness

Juvent was never meant to be just another wellness device. It exists because of a simple idea: The body already knows how to stay strong, if you give it the right micro impact.

This is not about pushing harder. This is not about extremes. This is not about quick fixes.

It’s about supporting your body consistently, safely, and intelligently over time. From NASA-supported research to daily use in homes around the world, Juvent continues to follow the same guiding principle: Do what actually helps people.

Because in the end, this was never about building a product. It was about building something people could rely on to make them feel better and be stronger every single day.